Last updated: October 18, 2010
Sponsor: Yuzuncu Yıl University
Overall Status: Completed
Phase
3
Condition
Atopic Dermatitis
Allergy
Dermatitis, Atopic
Treatment
N/AClinical Study ID
NCT01224132
JID-2010-0484
Ages 8-8 All Genders Accepts Healthy Volunteers
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:SCORAD (SCORing Atopic Dermatitis) index is based on medium-heavy (Carr 2006). Age range is 1-13 with no patient showing evidence of any other disease except theexistent disease -
Exclusion
Exclusion Criteria:No drug was used for 14 (fourteen) days prior to study, includingantihistamines and steroids. Also, no occurrence of malabsorption, such as gastrointestinaldisease, was detected.
Study Design
Total Participants: 40
Study Start date:
October 01, 2007
Estimated Completion Date:
April 30, 2008